Dilip Shanghvi (#106)
Our story is all about incremental growth. We're not looking for big leaps; we prefer small jumps.
- $ 24 B
- Pharmaceuticals
- India
- M
- 70 Years
Maine Said No to New Data Centers. Other States Are Racing to Follow.
New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer
The EV Collapse in America Shows Early Signs of Relenting
Zayn Malik hospitalized on day of album release and thanks nurses and cardiologist as he’s ‘recovering’
EagleRock Files for IPO
Soccer standout Megan Rapinoe and basketball star Sue Bird announce split after a decade together
US Section 301 probe: India textile body TEXPROCIL pushes back on USTR excess capacity allegations
College Football Best Bets and Transfer Portal Buy, Sell, or Hold: Brendan Sorsby Shows Heisman Value
Revealed: Manchester United wonderkid rejects transfer approach from Manchester City
FFB Bancorp Announces First Quarter 2026 Results:
About Me
The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs. The company is India's most valuable listed pharma outfit and gets two-thirds of its $6.1 billion annual revenue from overseas markets. He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion. Sun Pharma acquired U.S. skin cancer drug maker Checkpoint Therapeutics in May 2025 for $355 million. In February 2025, his son Aalok was appointed as chief operating officer of Sun Pharma.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Dilip Shanghvi’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Dilip Shanghvi’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $24.3B
(April 19, 2026)
© Iconic Billionaires